TABLE 1

Patient Clinical Characteristics at Study Entry

Patient no.SexAge (y)Histologic diagnosis of LGG (WHO grade II)Confirmation of histologyDiagnosis of LGG before baseline PETInitial treatment of LGG before baseline PETInitial treatment of LGG after baseline PETTime between initial diagnosis and malignant progression (mo)Histologic diagnosis after malignant progressionWHO gradeConfirmation of histology
1M56AResectionYesResectionResection106AAIIIResection
2M36AResectionYesResectionResection64AOAIIIResection
3M33ABiopsyNoNoWW44AOAIIIResection
4F40AResectionYesResectionResection53AAIIIResection
5M43ABiopsyNoNoWW4GBMIVResection
6M11ABiopsyNoNoWW15AAIIIBiopsy
7F48ABiopsyNoNoWW5AAIIIResection
8M38OAResectionNoNoResection15AOAIIIResection
9M85AResectionNoNoResection10AAIIIResection
10F28EResectionNoNoResection19EIIIResection
11M40ODGBiopsyNoNoWW11AODGIIIBiopsy
12M47ABiopsyNoNoWW29AAIIIBiopsy
13M50ODGResectionNoNoRTx, CTx21GBMIVResection
14M27ABiopsyNoNoResection22AAIIIResection
15M64AResectionNoNoResection16GBMIVBiopsy
16M51AResectionYesResectionResection83AAIIIResection
17F57ABiopsyNoNoWW21GBMIVBiopsy
18M43ABiopsyYesWWWW25AOAIIIBiopsy
19M40OABiopsyYesWWWWNo malignant progressionOAIIResection
20M24ABiopsyNoNoWWNo malignant progressionOAIIResection
21M49OABiopsyYesRTxCTxNo malignant progressionOAIIResection
22M56AResectionNoNoWWNo malignant progressionAIIResection
23F20OABiopsyNoNoCTxNo malignant progressionOAIIResection
24F54ABiopsyNoNoWWNo malignant progressionAIIBiopsy
25F43ABiopsyNoNoRTx, CTxNo malignant progressionAIIResection
26F62OAResectionNoNoCTxNo malignant progressionOAIIResection
27M45AResectionNoNoRTxNo malignant progressionAIIBiopsy
  • A = astrocytoma; AA = anaplastic astrocytoma; AOA = anaplastic oligoastrocytoma; WW = watch-and-wait strategy; GBM = glioblastoma; OA = oligoastrocytoma; E = ependymoma; ODG = oligodendroglioma; AODG = anaplastic oligodendroglioma; RTx = radiation therapy; CTx = chemotherapy.